Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - BIT:1ELX - US5184391044 - Common Stock

73.6 EUR
-5 (-6.36%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

3

Overall 1ELX gets a fundamental rating of 3 out of 10. We evaluated 1ELX against 13 industry peers in the Personal Care Products industry. 1ELX may be in some trouble as it scores bad on both profitability and health. 1ELX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

1ELX had positive earnings in the past year.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in 4 of the past 5 years.
In the past 5 years 1ELX always reported a positive cash flow from operatings.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

The Return On Assets of 1ELX (-5.70%) is worse than 92.31% of its industry peers.
1ELX's Return On Equity of -29.31% is on the low side compared to the rest of the industry. 1ELX is outperformed by 92.31% of its industry peers.
With a Return On Invested Capital value of 4.17%, 1ELX is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
1ELX had an Average Return On Invested Capital over the past 3 years of 4.98%. This is significantly below the industry average of 12.42%.
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROIC 4.17%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

Looking at the Operating Margin, with a value of 7.94%, 1ELX is doing worse than 76.92% of the companies in the same industry.
1ELX's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 73.96%, 1ELX is doing good in the industry, outperforming 76.92% of the companies in the same industry.
1ELX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.94%
PM (TTM) N/A
GM 73.96%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ELX is destroying value.
Compared to 1 year ago, 1ELX has more shares outstanding
1ELX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1ELX has a worse debt to assets ratio.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 3.06 indicates that 1ELX is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.06, 1ELX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
1ELX has a debt to FCF ratio of 10.92. This is a negative value and a sign of low solvency as 1ELX would need 10.92 years to pay back of all of its debts.
1ELX has a Debt to FCF ratio of 10.92. This is in the lower half of the industry: 1ELX underperforms 76.92% of its industry peers.
A Debt/Equity ratio of 1.89 is on the high side and indicates that 1ELX has dependencies on debt financing.
The Debt to Equity ratio of 1ELX (1.89) is worse than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Altman-Z 3.06
ROIC/WACC0.55
WACC7.54%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.30. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.30, 1ELX is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
A Quick Ratio of 0.92 indicates that 1ELX may have some problems paying its short term obligations.
The Quick ratio of 1ELX (0.92) is better than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

1ELX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.31%.
The earnings per share for 1ELX have been decreasing by -18.22% on average. This is quite bad
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -8.24%.
1ELX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.04% yearly.
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%

3.2 Future

The Earnings Per Share is expected to grow by 28.94% on average over the next years. This is a very strong growth
1ELX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.33% yearly.
EPS Next Y48.59%
EPS Next 2Y42.44%
EPS Next 3Y37.52%
EPS Next 5Y28.94%
Revenue Next Year3.27%
Revenue Next 2Y3.72%
Revenue Next 3Y4.19%
Revenue Next 5Y3.33%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 57.05, which means the current valuation is very expensive for 1ELX.
Compared to the rest of the industry, the Price/Earnings ratio of 1ELX indicates a rather expensive valuation: 1ELX more expensive than 84.62% of the companies listed in the same industry.
1ELX is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 38.50 indicates a quite expensive valuation of 1ELX.
1ELX's Price/Forward Earnings ratio is rather expensive when compared to the industry. 1ELX is more expensive than 84.62% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1ELX to the average of the S&P500 Index (22.71), we can say 1ELX is valued expensively.
Industry RankSector Rank
PE 57.05
Fwd PE 38.5
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued a bit more expensive than the industry average as 76.92% of the companies are valued more cheaply.
1ELX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1ELX is more expensive than 76.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.09
EV/EBITDA 18.92
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

1ELX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1ELX's earnings are expected to grow with 37.52% in the coming years.
PEG (NY)1.17
PEG (5Y)N/A
EPS Next 2Y42.44%
EPS Next 3Y37.52%

3

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.53%. Purely for dividend investing, there may be better candidates out there.
1ELX's Dividend Yield is slightly below the industry average, which is at 2.90.
Compared to the average S&P500 Dividend Yield of 2.38, 1ELX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

On average, the dividend of 1ELX grows each year by 9.59%, which is quite nice.
Dividend Growth(5Y)9.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1ELX are negative and hence is the payout ratio. 1ELX will probably not be able to sustain this dividend level.
The dividend of 1ELX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-54.55%
EPS Next 2Y42.44%
EPS Next 3Y37.52%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (9/16/2025, 7:00:00 PM)

73.6

-5 (-6.36%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-20 2025-08-20/bmo
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners94.25%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap26.49B
Analysts68.33
Price Target72.61 (-1.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend2.27
Dividend Growth(5Y)9.59%
DP-54.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.72%
Min EPS beat(2)0.44%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)57.77%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)83.43%
EPS beat(12)11
Avg EPS beat(12)80.65%
EPS beat(16)15
Avg EPS beat(16)63.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-2.01%
Revenue beat(8)0
Avg Revenue beat(8)-2.21%
Revenue beat(12)1
Avg Revenue beat(12)-1.91%
Revenue beat(16)3
Avg Revenue beat(16)-1.8%
PT rev (1m)4.78%
PT rev (3m)4.19%
EPS NQ rev (1m)-27.37%
EPS NQ rev (3m)-47.42%
EPS NY rev (1m)-2.47%
EPS NY rev (3m)-8.63%
Revenue NQ rev (1m)1.28%
Revenue NQ rev (3m)0.4%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 57.05
Fwd PE 38.5
P/S 2.16
P/FCF 46.09
P/OCF 24.28
P/B 7.99
P/tB N/A
EV/EBITDA 18.92
EPS(TTM)1.29
EY1.75%
EPS(NY)1.91
Fwd EY2.6%
FCF(TTM)1.6
FCFY2.17%
OCF(TTM)3.03
OCFY4.12%
SpS34.14
BVpS9.21
TBVpS-4.84
PEG (NY)1.17
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROCE 7.86%
ROIC 4.17%
ROICexc 5.22%
ROICexgc 10.68%
OM 7.94%
PM (TTM) N/A
GM 73.96%
FCFM 4.68%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexcg growth 3Y-33.25%
ROICexcg growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Debt/EBITDA 3.72
Cap/Depr 72.62%
Cap/Sales 4.2%
Interest Coverage 3.22
Cash Conversion 64.7%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.92
Altman-Z 3.06
F-Score4
WACC7.54%
ROIC/WACC0.55
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
EPS Next Y48.59%
EPS Next 2Y42.44%
EPS Next 3Y37.52%
EPS Next 5Y28.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%
Revenue Next Year3.27%
Revenue Next 2Y3.72%
Revenue Next 3Y4.19%
Revenue Next 5Y3.33%
EBIT growth 1Y-27.35%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year100.09%
EBIT Next 3Y38.66%
EBIT Next 5Y28.47%
FCF growth 1Y-53.5%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-46.1%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%